Company Filing History:
3 out of 24 
3 out of 290 
1 out of 119 Years Active: 2019-2024
Title: The Innovative Contributions of Michael Monrad Grandal
Introduction
Michael Monrad Grandal is a notable inventor based in Ballerup, Denmark. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of seven patents to his name, Grandal's work focuses on enhancing immunity and developing therapies for cancer treatment.
Latest Patents
Among his latest patents are the "Anti-NKG2A antibodies and compositions," which relate to methods of using these antibodies to enhance immunity in patients and treat cancer. Another significant patent is for "Combination therapies targeting PD-1, TIM-3, and LAG-3." This invention involves using antibodies specific to these targets to improve immunity in patients, particularly those suffering from various cancers.
Career Highlights
Grandal has worked with prominent companies in the pharmaceutical industry, including Symphogen A/S and Les Laboratoires Servier. His experience in these organizations has allowed him to contribute to groundbreaking research and development in immunotherapy.
Collaborations
Throughout his career, Grandal has collaborated with talented individuals such as Michael Kragh and Mikkel Wandahl Pedersen. These partnerships have further enriched his work and expanded the impact of his inventions.
Conclusion
Michael Monrad Grandal's innovative patents and contributions to immunology highlight his role as a leading inventor in the field. His work continues to influence cancer treatment and enhance patient immunity.